Kelvin Teo, MBBS, PhD, senior consultant, Advanced Eye Clinic & Surgery, adjunct associate professor, Duke NUS Eye ACP, Singapore, presents real-world data showing that a single 8-mg dose…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
Many symptoms are associated with the neurodegenerative disease Parkinson’s Disease, including shortened stride, tremors, reduced blink rate, and shuffling gate due to the degeneration of the brain. Neurologist…
Blepharospasm is a neurological movement disorder linked to uncontrollable squeezing and blinking of the eyes, potentially making any task that involves vision difficult. Botox was originally developed as…
Anthony Lang, OC, MD, FRCPC, FAAN, FCAHS, FRSC, Director of the Movement Disorders Clinic at the Krembil Neuroscience Center, discusses the investigational treatment PRX002 and other antibodies for…
Patients with Parkinson’s may experience “on-off” fluctuations, which are changes in the ability to move and are usually related to medication timing. These fluctuations can result in the…
52 months after a suggestive brain scan indicated a strong possibility of CTE in a former NFL player, the diagnosis has been confirmed by autopsy following the ex-players…
Eleanor K. Orehek, MD shares details of some new delivery methods for carbidopa/levodopa in patients with Parkinson’s disease. Among the promising new technologies are a credit card-sized wearable…
